Lannett Company Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Oct 21, 2022
  • 1 Class I recall
  • Last warning letter 2009
Inspections 21 1 OAI
Recalls 15 1 Class I (7%)
Warning letters 1 Latest Mar 30, 2009
510(k) clearances 0 None on file

Lannett Company Inc. has 15 FDA recalls (1 Class I), 21 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Lannett Company Inc., the most recent on Mar 30, 2009.

What these totals cover: FDA records filed under the name "Lannett Company Inc." and its spelling variant "Lannett Company".

Latest recall
D-0660-2026 · Class II · Jun 26, 2026
Latest inspection
Oct 21, 2022 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls15 (1 Class I)Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections21Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Lannett Company Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Lannett Company Inc.: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 2 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 3 recall records (1 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 2 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 3 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600030
202500030
202400010
202300000
202220030
202100000
202000010
201910031
201820010
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Lannett Company Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Lannett Company Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Lannett Company Inc. FDA Warning Letters

1 warning letter on Mar 30, 2009.

IssuedSubjectIssuing officeClose-out letter
Mar 30, 2009 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

15 recall records from Oct 11, 2018 to Jun 26, 2026.

NumberClassProductDate
D-0660-2026Class IIDextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and…Jun 26, 2026
D-0584-2026Class IINiacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett…May 27, 2026
D-0533-2026Class IIIPrimidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc…Apr 24, 2026
D-0096-2026Class IINiacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by…Oct 10, 2025
D-0642-2025Class IIDextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine…Aug 19, 2025
D-0599-2025Class IILisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett…Aug 11, 2025
D-0112-2025Class IILisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by…Oct 25, 2024
D-0160-2023Class IIITriamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per…Nov 9, 2022
D-0161-2023Class IIITriamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules…Nov 9, 2022
D-0558-2022Class IIDiazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and DROPPER, Rx Only…Feb 9, 2022
D-1508-2020Class IIPrednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett Company, Inc…Aug 10, 2020
D-0630-2020Class ILevetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Distributed by: Lannett…Dec 6, 2019
D-0309-2020Class IILannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distributed by: Lannett…Oct 28, 2019
D-0996-2019Class IIIOxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by…Feb 21, 2019
D-0083-2019Class IIHydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx…Oct 11, 2018

Recent FDA inspections

21 inspections from Sep 2, 2009 to Oct 21, 2022. Showing the 20 most recent. View all 21 inspections

DateSiteProductClassificationFEI
Oct 21, 2022Seymour, INDrugsVoluntary Action Indicated (VAI)1819171
Mar 25, 2022Philadelphia, PADrugsNo Action Indicated (NAI)2510865
Jan 25, 2019Philadelphia, PADrugsNo Action Indicated (NAI)2510865
Jul 23, 2018Seymour, INFood/CosmeticsVoluntary Action Indicated (VAI)1819171
Feb 2, 2018Seymour, INDrugsVoluntary Action Indicated (VAI)1819171
Jun 22, 2017Philadelphia, PADrugsNo Action Indicated (NAI)2510865
Sep 16, 2016Philadelphia, PADrugsVoluntary Action Indicated (VAI)2510865
Dec 16, 2014Seymour, INDrugsVoluntary Action Indicated (VAI)1819171
Aug 15, 2013Seymour, INDrugsVoluntary Action Indicated (VAI)1819171
Aug 6, 2013Philadelphia, PADrugsNo Action Indicated (NAI)2510865
Oct 31, 2012Seymour, INDrugsOfficial Action Indicated (OAI)1819171
Aug 29, 2012Seymour, INDrugsVoluntary Action Indicated (VAI)1819171
Aug 17, 2012Philadelphia, PADrugsVoluntary Action Indicated (VAI)2510865
May 13, 2011Seymour, INDrugsVoluntary Action Indicated (VAI)1819171
Mar 21, 2011Philadelphia, PADrugsVoluntary Action Indicated (VAI)2510865
Sep 14, 2010Philadelphia, PADrugsNo Action Indicated (NAI)3006174033
Sep 14, 2010Philadelphia, PADrugsNo Action Indicated (NAI)2510865
May 12, 2010Seymour, INDrugsVoluntary Action Indicated (VAI)1819171
Feb 9, 2010Philadelphia, PADrugsVoluntary Action Indicated (VAI)2510865
Feb 9, 2010Philadelphia, PADrugsVoluntary Action Indicated (VAI)2510865
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Lannett Company Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Mar 30, 2009.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

3 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1819171Seymour, IN10Oct 21, 2022
FEI 2510865Philadelphia, PA10Mar 25, 2022
FEI 3006174033Philadelphia, PA1Sep 14, 2010

Lannett Company Inc. and the FDA: common questions

Has Lannett Company Inc. received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Lannett Company Inc.. The most recent is dated Mar 30, 2009.

Has Lannett Company Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Lannett Company Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Lannett Company Inc.?

The most recent FDA inspection on file ended Oct 21, 2022 at Seymour, IN and was classified VAI. FDA has 21 inspections of Lannett Company Inc. on file, 1 of them classified OAI (official action indicated).

Has Lannett Company Inc. had an FDA recall?

Yes. Lannett Company Inc. has 15 FDA recalls on record, 1 of them Class I, the most serious class. The most recent started Jun 26, 2026.

Need more than this page shows? Ask about Lannett Company Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.